-
The iMOST platform is not only fast, user-friendly, and cost-effective, but it also ensures the accuracy and reliability of clinical lab-quality test results 9 月. 10, 2024Essenlix’s iMOST platform represents a significant leap forward in digital health technology. Designed as an industry-first, it enables individuals to conduct self-evaluations for various diseases and…
-
Essenlix Partners with Roche Diagnostics Norway to Employ Essenlix’s iMOST platform represents 5 月. 20, 2021PRINCETON, N.J., May 20, 2021 /PRNewswire/ -- Essenlix Corporation, a premier developer, manufacturer, and provider of mobile instant health test solutions for personal, point-of-care, and clinical us…